-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Test Results
Test Description
Clinical Recommendations
Disclaimers
COV-13C25 Rapid Response COVID-19 IgG/IgM Test
IgG NEGATIVE
IgM NEGATIVE
Specimen Type serum
COV-13C25 Rapid Response COVID-19 IgG/IgM TestDeveloped by BTNX
Inc., the COV-13C25 Rapid Response™ COVID-19 IgG/IgM Test Cassette
is an in vitro immunoassay for the direct and qualitativedetection
of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole
blood, serum, or plasma as an aid in the diagnosis of COVID-19.
Please discuss these results with your physician.
COV-13C25 Rapid Response COVID-19 IgG/IgM TestThe test has not
been reviewed by the FDA. Negative results do not rule out
SARS-CoV-2 infection, particularly in those who have been in
contact with thevirus. Follow-up testing with a molecular
diagnostic should be considered to rule out infection in these
individuals. Results from antibody testing should not beused as the
sole basis to diagnose or exclude SARS-CoV-2 infection or to inform
infection status. Positive results may be due to past or present
infection withnon-SARS-CoV-2 coronavirus strains, such as
coronavirus HKU1, NL63, OC43, or 229E.
Positive test results (IgG/IgM antibodies present) do not
guarantee immunity to reinfection.Positive test results (IgG/IgM
antibodies present) do not guarantee a patient is no longer an
active carrier of the disease.Antibody testing should be always be
used in conjunction with laboratory testing methods to diagnose
active infections.Tests must be administered and interpreted by
healthcare professionals, subject to the governing regulatory body
overseeing diagnostic testing in the region ofuse.
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 1
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 2
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 3
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 4
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 5
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 6
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
-
LABORATORY RESULTSStageZero COVID-19 Antibody Testing
Pat
ien
t
Sp
ecim
en
Pro
vid
er
Name: Phone #: Patient ID #:
Fasting Status: Gender Birthdate: Age:
Height: Weight: BMI: Prev. BMI:
Collection Time: Specimen ID:
Collection Date: Report Type:
Received Date: Report Date:
Requesting Provider
Client ID:
John Partick Doe 09:15 A123456789
2020-10-08 F
ZALZALA, SAJAD, MDRoot Cause Medical835 Mason St, STE
250Dearborn, MI 48124
02864
Dr. Leroy D. Mell, Jr. | Laboratory Director | CLIA No.
49D2059683 | NPI No. 1437710415©2020 StageZero Life Sciences | 8751
Park Central Drive, Suite 200 | Richmond, VA 23227 |
www.StageZeroLifeSciences.comPage 7
Rpt ver: SZLS 1.0Ref ver: 2.0
Source:
![Ocala Evening Star. (Ocala, Florida) 1901-08-10 [p ].ufdcimages.uflib.ufl.edu/UF/00/07/59/08/02864/00153.pdfFIVE PER CENT fri4 I-NRUBBERJIRES Comineroigil ser-viceCASTORIA 20Payment](https://img.pdfslide.us/doc/110x75/5e072eaba0d81063fe31716b/ocala-evening-star-ocala-florida-1901-08-10-p-per-cent-fri4-i-nrubberjires.jpg)
